Erlotinib as Frontline Treatment for Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) and Non-Squamous Histology - Results of a Galician Lung Cancer Group (GGCP044/09 Study) Grupo Galego De Cancro De Pulmon (GGCP)

被引：0
|
作者：
Firvidal, J. L. [1 ]
Vazquez, S. [2 ]
Casal, J. [3 ]
Fernandez, A. [1 ]
Varela, S. [2 ]
Villanueva, M. J. [3 ]
Perez, E. [1 ]
Campos, B. [2 ]
Salgado, M. [1 ]
Mel, J. R. [2 ]
机构：
[1] Complexo Hosp Ourense, Orense, Spain
[2] Hosp Lucus Augusti, Lugo, Spain
[3] Univ Vigo, Complexo Hosp, Vigo 36310, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72400-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S619 / S619
页数：1
相关论文
共 50 条
  • [41] Phase II pharmacodynamic trial of erlotinib in previously treated patients with advanced non-small-cell lung cancer (NSCLC):: Study results
    Felip, Enriqueta
    Rojo, Frederico
    Reck, Martin
    Heller, Astrid
    Klughammer, Barbara
    Maacke, Heiko
    Mocks, Joachim
    Brennscheidt, Ulrich
    Gatzemeier, Ulrich
    Baselga, Jose
    ANNALS OF ONCOLOGY, 2006, 17 : 235 - 235
  • [42] RETROSPECTIVE ANALYSIS OF TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH ADVANCED AND RECURRENT NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER IN OUR INSTITUTE
    Yoshino, R.
    Tomizawa, Y.
    Miura, Y.
    Nishioka, M.
    Yoshii, A.
    Watanabe, S.
    Saitou, R.
    Mori, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 135 - 135
  • [43] Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study
    Boyer, Michael
    Horwood, Keith
    Pavlakis, Nick
    De Souza, Paul
    Millward, Michael
    Stein, Brian
    Johnston, Michael
    Abell, Fiona
    Rischin, Danny
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (03) : 248 - 254
  • [44] A PHASE II STUDY OF PEMETREXED IN CHEMOTHERAPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER: HANSHIN ONCOLOGY GROUP 003
    Namba, Y.
    Hattori, Y.
    Edagawa, M.
    Yoshioka, H.
    Iwasaku, M.
    Shimada, T.
    Satouchi, M.
    Katagami, N.
    Fujita, S.
    Mori, M.
    Imamura, F.
    Kotani, Y.
    Nishimura, T.
    Morita, S.
    Negoro, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 86 - 86
  • [45] A PHASE II STUDY OF PEMETREXED IN CHEMOTHERAPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER: HANSHIN ONCOLOGY GROUP 003
    Hattori, Yoshihiro
    Satouchi, Miyako
    Kotani, Yoshikazu
    Yoshioka, Hiroshige
    Iwasaku, Masahiro
    Katakami, Nobuyuki
    Fujita, Shiro
    Otsuka, Kojiro
    Yokota, Soichiro
    Namba, Yoshinobu
    Imamura, Fumio
    Nishimura, Takashi
    Fujita, Kanako
    Morita, Satoshi
    Negoro, Shunichi
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S489
  • [46] A PHASE II STUDY OF PEMETREXED IN CHEMOTHERAPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER: HANSHIN ONCOLOGY GROUP 003
    Iwasaku, M.
    Hattori, Y.
    Morita, S.
    Yoshioka, H.
    Otsuka, K.
    Katakami, N.
    Fujita, S.
    Yokota, S.
    Imamura, F.
    Negoro, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 422 - 422
  • [47] Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
    Ben Rothwell
    Christopher Kiff
    Caroline Ling
    Thor-Henrik Brodtkorb
    PharmacoEconomics - Open, 2021, 5 : 251 - 260
  • [48] Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
    Rothwell, Ben
    Kiff, Christopher
    Ling, Caroline
    Brodtkorb, Thor-Henrik
    PHARMACOECONOMICS-OPEN, 2021, 5 (02) : 251 - 260
  • [49] Clinical Study of Pemetrexed as the First-line Treatment in Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Pu Xiaolin
    Wang Jun
    Li Wei
    Lu Binbin
    Wang Zhaoxia
    Yang Min
    Fan Weifei
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (04): : 205 - 209
  • [50] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345